Magnus Fugger

Novo Nordisk A/S, Denmark

Poster(s):

• (C-162) A Fitness-for-use Assessment of Real-World Data Sources and Data Linkage to inform a Post-Authorization Safety Study - A Formalized Feasibility Study
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET